Evidence map›Paper›PMID 37193644›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Ultrasound-Responsive Oxygen-Carrying Pollen for Enhancing Chemo-Sonodynamic Therapy of Breast Cancer.

Baojie Wen, Danqing Huang, Chuanhui Song, Jingyang Shan, Yuanjin Zhao

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. [Research progress on the application of pollen in the biomedical field].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Review
  3. Stimuli-Responsive Supramolecular Biomaterials for Cancer Theranostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Article
  5. Emerging Nanozyme Strategies for Precision Breast Cancer Treatment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Baojie WenDepartment of Ultrasound, Institute of Translational Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medicine School, Nanjing University, Nanjing, 210008, China.ORCID 0000-0001-5692-7057
Danqing HuangDepartment of Ultrasound, Institute of Translational Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medicine School, Nanjing University, Nanjing, 210008, China.
Chuanhui SongDepartment of Ultrasound, Institute of Translational Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medicine School, Nanjing University, Nanjing, 210008, China.
Jingyang ShanDepartment of Ultrasound, Institute of Translational Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medicine School, Nanjing University, Nanjing, 210008, China.
Yuanjin ZhaoDepartment of Ultrasound, Institute of Translational Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medicine School, Nanjing University, Nanjing, 210008, China.ORCID 0000-0001-9242-4000
Nanjing Drum Tower Hospital · CN

Funding

Clinical Trials from Nanjing Drum Tower Hospital 2022-LCYJ-ZD-01Guangdong Basic and Applied Basic Research Foundation 2021B1515120054Nanjing Medical Science and Technique Development Foundation ZKX21019National Key Research and Development Program of China 2020YFA0908200National Natural Science Foundation of China 52073060National Natural Science Foundation of China T2225003Shenzhen Fundamental Research Program JCYJ20190813152616459Shenzhen Fundamental Research Program JCYJ20210324133214038
6 · The paper itself

Abstract

The tumor-suppressing efficacy of either chemotherapeutics or gaseous drugs has been confirmed in treating the triple negative breast cancer (TNBC), while the efficacy of single treatment is usually dissatisfactory. Herein, a novel ultrasound responsive natural pollen delivery system is presented to simultaneously load chemotherapeutics and gaseous drugs for synergistic treatment of TNBC. The hollow structure of pollen grains carries oxygen-enriched perfluorocarbon (PFC), and the porous spinous process structure adsorbs the chemotherapeutic drug doxorubicin (DOX) (PO/D-PGs). Ultrasound can trigger the oxygen release from PFC and excite DOX, which is not only a chemotherapeutic but also a sonosensitizer, to realize chemo-sonodynamic therapy. The PO/D-PGs are demonstrated to effectively enhance oxygen concentration and increase the production of reactive oxygen species in the presence of low-intensity ultrasound, synergistically enhancing the tumor killing ability. Thus, the synergistic therapy based on ultrasound-facilitated PO/D-PGs significantly enhances the antitumor effect in the mouse TNBC model. It is believed that the proposed natural pollen cross-state microcarrier can be used as an effective strategy to enhance chemo-sonodynamic therapy for TNBC.

Indexed as

NanoparticlesTriple Negative Breast NeoplasmsAnimalsCombined Modality TherapyDoxorubicinHumansMiceOxygenDoxorubicinOxygenchemo-sonodynamic therapydrug deliverymicrocarrieroxygen carryingpollen

Identifiers

PMID37193644
PMCPMC10375146
OpenAlexW4376873115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.